Differential display RT-PCR analysis of human choriocarcinoma cell lines and normal term trophoblast cells: Identification of new genes expressed in placenta

Placenta

Volumn 25, Issue 8-9, 2004, Pages 684-693

  Garcia J ^a   Castrillo, J L ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DNA FRAGMENT; FIBRONECTIN; GENE PRODUCT; HOMOCYSTEINE; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 2; PREGNANCY ASSOCIATED PROTEIN; TUMOR REJECTION ANTIGEN; UBIQUITIN;

ALTERNATIVE RNA SPLICING; ARTICLE; CARCINOGENESIS; CHORIOCARCINOMA; CHROMOSOME 16Q; CHROMOSOME 6Q; CHROMOSOME 9Q; CONTROLLED STUDY; CYTOLOGY; DIFFERENTIAL DISPLAY; DNA DETERMINATION; DNA ISOLATION; FEMALE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC CODE; HUMAN; HUMAN CELL; HUMAN GENOME; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PLACENTA; PLACENTA DISORDER; PRIORITY JOURNAL; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; TROPHOBLAST; TUMOR CELL LINE;

ADULT; CELL LINE, TUMOR; CHORIOCARCINOMA; DNA, COMPLEMENTARY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PREGNANCY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TROPHOBLASTS; UTERINE NEOPLASMS;

EID: 4444244818     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2003.10.020     Document Type: Article

References (41)

1. Morrish D.W. Dakour J. Li H. Functional regulation of human trophoblast differentiation J Reprod Immunol 39 1998 179-195
2. Kacsoh B. Endocrine physiology 2000 448-639 McGraw-Hill USA
3. Seckl M.J. Fisher R.A. Salerno G. Rees H. Paradinas F.J. Foskett M. et al. Choriocarcinoma and partial hydatidiform moles Lancet 356 2000 36-39
4. Li H.W. Tsao S.W. Cheung A.N.Y. Current understanding of the molecular genetics of gestational trophoblastic diseases Placenta 23 2002 20-31
5. Kozian D.H. Kirschbaum B.J. Comparative gene-expression analysis Trends Biotechnol 17 1999 73-78
6. Green C.D. Simons J.F. Taillon B.E. Lewin D.A. Open systems: panoramic views of gene expression J Immunol Methods 250 2001 67-79
7. Liang P. A decade of differential display Biotechniques 33 2002 338-346
8. Pak B.J. Park H. Chang E.R. Pang S.C. Graham C.H. Differential display analysis of oxygen-mediated changes in gene expression in first trimester human trophoblast cells Placenta 19 1998 483-488
9. Huch G. Hohn H.-P. Denker H.-W. Identification of differentially expressed genes in human trophoblast cells by differential-display RT-PCR Placenta 19 1998 557-567
10. Xu B. Lin L. Rote N.S. Identification of a stress-induced protein during human trophoblast differentiation by differential display analysis Biol Reprod 61 1999 681-686
11. Rao R.M. Dharmarajan A.M. Rao A.J. Cloning and characterization of an apoptosis-associated gene in the human placenta Apoptosis 5 2000 53-60
12. Lee B.P.-L. Rushlow W.J. Chakraborty C. Lala P.K. Differential gene expression in premalignant human trophoblast: role of IGFBP-5 Int J Cancer 94 2001 674-684
13. Durand S. Dumur C. Flury A. Abadie P. Patrito L. Podhajcer O. et al. Altered mitochondrial gene expression in human gestational trophoblastic diseases Placenta 22 2001 220-226
14. Chomczynsky P. Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal Biochem 162 1987 156-159
15. Ausubel F.M. Brent R. Kingston R.E. Moore D.D. Seidman J.G. Smith J.A. et al. Current protocols in molecular biology 1989 Greene Publishing Associates, Wiley Interscience
16. Goda S.K. Minton N.P. A simple procedure for gel electrophoresis and Northern blotting of RNA Nucleic Acids Res 23 1995 3357-3358
17. Kruithof E.K.O. Baker M.S. Bunn C.L. Biological and clinical aspects of plasminogen activator inhibitor type 2 Blood 86 1995 4007-4024
18. Peters T. Ausmeier K. Rüther U. Cloning of Fatso (Fto), a novel gene deleted by the Fused toes (Ft) mouse mutation Mamm Genome 10 1999 983-986
19. Suehiro Y. Umayahara K. Ogata H. Numa F. Yamashita Y. Oga A. et al. Genetic aberrations detected by comparative genomic hybridization predict outcome in patients with endometrioid carcinoma Genes Chromosomes Cancer 29 2000 75-82
20. Williams S.V. Sibley K.D. Davies A.M. Nishiyama H. Hornigold N. Coulter J. et al. Molecular genetic analysis of chromosome 9 candidate tumor-suppressor loci in bladder cancer cell lines Genes Chromosomes Cancer 34 2002 86-96
21. Callahan G. Denison S.R. Phillips L.A. Shridhar V. Smith D.I. Characterization of the common fragile site FRA9E and its potential role in ovarian cancer Oncogene 22 2003 590-601
22. Frosk P. Weiler T. Nylen E. Sudha T. Greenberg C.R. Morgan K. et al. Limb-girdle muscular dystrophy type 2H associated with mutation in Trim32, a putative E3-ubiquitin-ligase gene Am J Hum Genet 70 2002 663-672
23. Löwer R. Löwer J. Kurth R. The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences Proc Natl Acad Sci U S A 93 1996 5177-5184
24. Harris J.R. Placental endogenous retrovirus (ERV): structural, functional, and evolutionary significance Bioessays 20 1998 307-316
25. Lin L. Xu B. Rote N.S. Expression of endogenous retrovirus ERV-3 induces differentiation in BeWo, a choriocarcinoma model of human placental trophoblast Placenta 20 1999 109-118
26. Mi S. Lee X. Li X.-P. Veldman G.M. Finnerty H. Racie L. et al. Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis Nature 403 2000 785-789
27. Krief P. Augery-Bourget Y. Plaisance S. Merck M.-F. Assier E. Tanchou V. et al. A new cytokine (IK) down-regulating HLA class II: monoclonal antibodies, cloning and chromosome localization Oncogene 9 1994 3449-3456
28. Assier E. Bouzinba-Segard H. Stolzenberg M.-C. Stephens R. Bardos J. Freemont P. et al. Isolation, sequencing and expression of RED, a novel human gene encoding an acidic-basic dipeptide repeat Gene 230 1999 145-154
29. Murphy S.P. Tomasi T.B. Absence of MHC class II antigen expression in trophoblast cells results from a lack of class II transactivator (CIITA) gene expression Mol Reprod Dev 51 1998 1-12
30. Wallin R.P.A. Lundqvist A. Moré S.H. von Bonin A. Kiessling R. Ljunggren H.-G. Heat-shock proteins as activators of the innate immune system Trends Immunol 23 2002 130-135
31. Parcellier A. Gurbuxani S. Scmitt E. Solary E. Garrido C. Heat shock proteins, cellular chaperones that modulate mitochondrial cell death pathways Biochem Biophys Res Commun 304 2003 505-512
32. van Laar T. Schouten T. Hoogervorst E. van Eck M. van der Eb A.J. Terleth C. The novel MMS-inducible gene Mif1/KIAA0025 is a target of the unfolded protein response pathway FEBS Lett 469 2000 123-131
33. Upadhya S.C. Hegde A.N. A potential proteasome-interacting motif within the ubiquitin-like domain of parkin and other proteins Trends Biochem Sci 28 2003 280-283
34. Gong L. Li B. Millas S. Yeh E.T.H. Molecular cloning and characterization of human AOS1 and UBA-2, components of the sentrin-activating enzyme complex FEBS Lett 448 1999 185-189
35. Yeh E.T.H. Gong L. Kamitani T. Ubiquitin-like proteins: new wines in new bottles Gene 248 2000 1-14
36. Müller S. Hoege C. Pyrowolakis G. Jentsch S. SUMO, ubiquitin's mysterious cousin Nat Rev Mol Cell Biol 2 2001 202-210
37. Ito M. Yuan C.-X. Malik S. Gu W. Fondell J.D. Yamamura S. et al. Identity between TRAP and SMCC complexes indicates novel pathways for the function of nuclear receptors and diverse mammalian activators Mol Cell 3 1999 361-370
38. Boube M. Joulia L. Cribbs D.L. Bourbon H.-M. Evidence for a mediator of RNA polymerase II transcriptional regulation conserved from yeast to man Cell 110 2002 143-151
39. Page N.M. Butlin D.J. Lomthaisong K. Lowry P.J. The characterization of pregnancy associated plasma protein-E and the identification of an alternative splice variant Placenta 22 2001 681-687
40. Dickinson J.L. Bates E.J. Ferrante A. Antalis T.M. Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor-alpha-induced apoptosis. Evidence for an alternative biological function J Biol Chem 270 1995 27894-27904
41. Nordengren J. Lidebring M.F. Bendhal P.-O. Brünner N. Fernö M. Högberg T. et al. High tumor tissue concentration of plasminogen activator inhibitor 2 (PAI-2) is an independent marker for shorter progression-free survival in patients with early stage endometrial cancer Int J Cancer 97 2002 379-385